$8.09
5.06% yesterday
NYSE, Sep 27, 10:10 pm CET
ISIN
US37611X1000
Symbol
DNA

Ginkgo Bioworks Target price 2024 - Analyst rating & recommendation

Ginkgo Bioworks Classifications & Recommendation:

Buy
17%
Hold
17%
Sell
67%

Ginkgo Bioworks Price Target

Target Price $14.80
Price $8.09
Potential
Number of Estimates 5
5 Analysts have issued a price target Ginkgo Bioworks 2025 . The average Ginkgo Bioworks target price is $14.80. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 1 Analysts recommend Ginkgo Bioworks to buy, 1 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ginkgo Bioworks stock has an average upside potential 2025 of . Most analysts recommend the Ginkgo Bioworks stock at Sale.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 251.46 185.95
47.36% 26.05%
EBITDA Margin -238.88% -188.36%
45.67% 21.15%
Net Margin -357.74% -233.79%
2,691.87% 34.65%

6 Analysts have issued a sales forecast Ginkgo Bioworks 2024 . The average Ginkgo Bioworks sales estimate is

$186m
Unlock
. This is
0.87% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$190m 3.07%
Unlock
, the lowest is
$180m 2.22%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $251m 47.36%
2024
$186m 26.05%
Unlock
2025
$209m 12.43%
Unlock
2026
$255m 21.99%
Unlock

4 Analysts have issued an Ginkgo Bioworks EBITDA forecast 2024. The average Ginkgo Bioworks EBITDA estimate is

$-350m
Unlock
. This is
38.47% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-291m 48.94%
Unlock
, the lowest is
$-389m 31.71%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-601m 71.40%
2024
$-350m 41.69%
Unlock
2025
$-200m 42.76%
Unlock
2026
$-120m 40.37%
Unlock

EBITDA Margin

2023 -238.88% 45.67%
2024
-188.36% 21.15%
Unlock
2025
-95.91% 49.08%
Unlock
2026
-46.88% 51.12%
Unlock

2 Ginkgo Bioworks Analysts have issued a net profit forecast 2024. The average Ginkgo Bioworks net profit estimate is

$-435m
Unlock
. This is
50.76% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-282m 68.08%
Unlock
, the lowest is
$-588m 33.44%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-900m 1,369.60%
2024
$-435m 51.67%
Unlock
2025
$-411m 5.49%
Unlock
2026
$-402m 2.07%
Unlock

Net Margin

2023 -357.74% 2,691.87%
2024
-233.79% 34.65%
Unlock
2025
-196.53% 15.94%
Unlock
2026
-157.75% 19.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -18.37 -8.88
1,369.60% 51.66%
P/E negative
EV/Sales 0.78

2 Analysts have issued a Ginkgo Bioworks forecast for earnings per share. The average Ginkgo Bioworks <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-8.88
Unlock
. This is
50.75% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-5.76 68.05%
Unlock
, the lowest is
$-12.00 33.44%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-18.37 1,369.60%
2024
$-8.88 51.66%
Unlock
2025
$-8.39 5.52%
Unlock
2026
$-8.22 2.03%
Unlock

P/E ratio

Current -0.45 82.14%
2024
-0.91 102.22%
Unlock
2025
-0.96 5.49%
Unlock
2026
-0.98 2.08%
Unlock

Based on analysts' sales estimates for 2024, the Ginkgo Bioworks stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.79 90.75%
2024
0.78 1.37%
Unlock
2025
0.69 11.05%
Unlock
2026
0.57 18.03%
Unlock

P/S ratio

Current 2.31 78.53%
2024
2.29 0.87%
Unlock
2025
2.03 11.05%
Unlock
2026
1.67 18.03%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today